HER2-NEGATIVE BREAST CANCER
Clinical trials for HER2-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets liver metastases in breast cancer patients
Disease control Not yet recruitingThis study tests whether combining a special heat treatment (multi-mode thermal therapy) with immunotherapy can help control HER2-negative breast cancer that has spread to the liver. It involves 30 women who have already tried at least one other treatment. The goal is to see if t…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Gene test may spare breast cancer patients from chemo
Disease control Not yet recruitingThis study tests a personalized approach for women with hormone receptor-positive, HER2-negative early breast cancer. Participants receive a combination of targeted pills (CDK4/6 inhibitors) and hormone therapy before surgery. A blood test (ctDNA) tracks genetic changes to see if…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Could a device help control advanced breast cancer?
Disease control Not yet recruitingThis study tests a device called TheraBionic P1 in 82 people with advanced or metastatic HR-positive, HER2-negative breast cancer who have already tried standard hormone therapies. The goal is to see if the device can slow cancer growth and improve survival. Participants will use…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Can training doctors and empowering patients improve breast cancer care?
Knowledge-focused Not yet recruitingThis study looks at whether training doctors in shared decision-making and giving patients educational materials can improve conversations about treatment for HER2-negative metastatic breast cancer. About 120 patients starting their first treatment will join, and their experience…
Matched conditions: HER2-NEGATIVE BREAST CANCER
Phase: NA • Sponsor: Federico II University • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC